Article Text

Download PDFPDF

OC49 Non-alcoholic fatty liver disease in obese and overweight iranian children: a cross sectional study
  1. Farzad Maleki1,
  2. Marjan Hosseinpour2,
  3. Bahman Mansouri motlagh3,
  4. Hadi Esmaeili Gouvarchin Ghaleh4,
  5. Shahsanam Gheibi2
  1. 1Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
  2. 2Maternal and Childhood Obesity Research Center, Urmia University of Medical Sciences, Urmia, Iran, Islamic Republic of
  3. 3Department of Pathobiology,Faculty Veterinary Medicine, Urmia University, Urmia, Iran, Islamic Republic of
  4. 4Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran, Islamic Republic of


Background Non-Alcoholic Fatty Liver Disease (NAFLD), the main cause of childhood liver abnormalities, is rising with the increase of pediatric obesity and overweight. This study aimed to investigate the prevalence of NAFLD and its predisposing factors in children of Urmia province, northwest of Iran.

Methods In this cross-sectional study, 508 overweight and obese children (251 boys) aged 6– 19 years were recruited by convenience sample from the Shahid Motahari Hospital during 2016–2017. The anthropometric and laboratory measurement and abdominal ultrasonography for liver echogenicity and size were conducted. A questionnaire was also used to obtain information on demographical characteristic and alcohol consumption. Eligibility criteria were: (1) 6 ≤ age ≤ 19 years; (2) BMI > 85th percentile for gender and age (3) absence of any drug toxicity; (5) abstinence from alcohol; (6) absence of hepatitis B, C and Wilson’s disease. Fatty liver was diagnosed by ultrasonography using standard criteria. Serum Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Alkaline Phosphate (ALK), Triglyceride (TG), Cholesterol (Chol), Low density lipoprotein (LDL) -cholesterol, High density lipoprotein (HDL)-cholesterol, Thyroid stimulating hormone (TSH) and glucose, were measured in children blood samples using standard laboratory methods. Insulin resistance was estimated using the homeostasis model assessment of the insulin resistance (HOMA-IR). Univariable and multivariable logistic regression and 95% confidence interval was used to evaluate predictors of NAFLD.

Results NAFLD was diagnosed in 8.5% of overweight and 24.9% of obese children. In obese children the prevalence of NAFLD was 22.3% for age group 6–11.9 years and 35.5% for age group 12–19 years. There was no significant difference between girls and boys (P= 0.521). Age was similar in children with and without NAFLD (P= 0.766). An increase of 10 U/L of ALT, AST and ALK increased the odds of NAFLD 6%, 5% and 3%, respectively. An increase of 10 mg/dl of triglycerides and glucose were associated with a 12% and 8% increase and one of TSH with a 15% increase in the odds of NAFLD. An increase of 1 unit of HOMA-IR was associated with a 21% increase in the odds of NAFLD.

Conclusions ALT, AST, ALK and HOMA-IR can predict the progression of NAFLD. Findings emphasize on the importance of prevention of obesity and early intervention to prevent abnormalities among obese children.

  • Keyword: NAFLD non-alcoholic fatty liver disease
  • pediatric obesity
  • overweight

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.